China Pharma Holdings (CPHI) EBT Growth (3y) (2013 - 2026)
China Pharma Holdings (CPHI) EBT Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn | 21.00% |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn | -0.23% |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn | 1.19% |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn | 3.60% |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | -29.91% |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn | 10.08% |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 39.40% |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | China Pharma Holdings | 42.14 Mn | 41.84 Mn | 83,566.00 | -34.97% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -33.92% |
| Dec 31, 2025 | 1.12% |
| Sep 30, 2025 | 6.25% |
| Jun 30, 2025 | 15.90% |
| Mar 31, 2025 | 8.62% |
| Dec 31, 2024 | -7.68% |
| Sep 30, 2024 | -10.58% |
| Jun 30, 2024 | -20.36% |
| Mar 31, 2024 | -7.60% |
| Dec 31, 2023 | -0.63% |
| Sep 30, 2023 | 8.34% |
| Jun 30, 2023 | -261.99% |
| Mar 31, 2023 | 10.36% |
| Dec 31, 2022 | 59.30% |
| Sep 30, 2022 | -4.10% |
| Jun 30, 2022 | -1.96% |
| Mar 31, 2022 | -35.08% |
| Dec 31, 2021 | 49.45% |
| Sep 30, 2021 | 25.72% |
| Jun 30, 2021 | 5.76% |